글로벌 대마 유래 카나비디올 시장 – 2031년까지의 산업 동향 및 예측

대마 유래 카나비디올 시장 분석 및 규모

제약 분야에서 대마에서 추출한 카나비디올(CBD)은 다양한 의학적 질환에 대한 치료제로서 유망합니다. 연구에 따르면 CBD는 간질, 불안 장애 , 만성 통증 및 기타 질환을 치료하는 데 잠재력이 있을 수 있습니다. 제약 회사는 CBD 기반 약물을 적극적으로 개발하고 임상 시험을 실시하여 효능과 안전성을 평가하고 있습니다. 이러한 약물은 환자, 특히 기존 의약품에 잘 반응하지 않는 환자에게 새로운 치료 옵션을 제공할 수 있습니다. 대마에서 추출한 CBD 시장의 제약적 적용은 충족되지 않은 의학적 요구를 해결하고 혁신적인 치료를 통해 환자 결과를 개선할 수 있는 중요한 기회를 나타냅니다.

글로벌 대마 추출 카나비디올 시장 규모는 2023년에 2억 685만 달러로 평가되었으며, 2031년까지 3억 6,076만 달러에 도달할 것으로 예상되며, 2024년에서 2031년까지의 예측 기간 동안 CAGR은 7.20%입니다. Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

보고 범위 및 시장 세분화       

Market Definition

Hemp-derived cannabidiol (CBD) is a compound extracted from the hemp plant known for its potential health benefits. Unsuch as THC, another compound found in cannabis, CBD doesn't induce psychoactive effects. It's commonly used in various wellness products such as oils, creams, and edibles for its reported calming and therapeutic properties.

Hemp-Derived Cannabidiol Market Dynamics

Drivers                                                                                          

• Growing Demand of Hemp-Derived Cannabidiol due to Increased Consumer Awareness

As information about the potential health benefits of CBD spreads, consumers are becoming more knowledgeable about its therapeutic properties, including pain relief, stress reduction, and sleep improvement. This heightened awareness has led to a growing interest in CBD products across a wide demographic, from health-conscious individuals seeking natural remedies to those exploring alternative treatments for various ailments. As more people share their positive experiences with CBD, word-of-mouth recommendations and testimonials further fuel consumer interest and confidence in these products. This increased awareness is driving demand for CBD-infused products, contributing significantly to market growth.

• Rapid Regulatory Changes Increases the Adoption of Hemp-Derived Cannabidiol

As governments worldwide revise laws surrounding hemp cultivation and CBD products, barriers to market entry are lowered, fostering increased production and distribution. Legalization provides clarity and legitimacy to the industry, attracting investment and encouraging innovation in product development and research. Regulatory changes often lead to the establishment of quality standards and testing requirements, enhancing consumer confidence in CBD products. This evolving regulatory landscape creates new opportunities for businesses to operate within compliant frameworks and expands the market reach of CBD products to a broader audience.

Opportunities

• Expansion of Distribution Channels Fosters the Demand of Hemp-Derived Cannabidiol

This expansion involves the inclusion of CBD products in diverse retail outlets such as online platforms, specialty stores, pharmacies, and even mainstream retailers. Increasing the availability of CBD products, companies can reach a broader customer base and capitalize on growing demand. The proliferation of distribution channels facilitates consumer education and awareness about CBD, driving further market growth. This trend is pivotal in fostering market expansion and establishing CBD products as mainstream consumer goods.

• Rising Research and Development Promotes Innovations in Hemp-Derived Cannabidiol

R&D efforts focus on understanding CBD's therapeutic properties and optimizing its extraction methods, formulation techniques, and delivery systems. This leads to the development of novel CBD-based products with enhanced efficacy, safety, and bioavailability. Additionally, ongoing research initiatives explore the pharmacological mechanisms of CBD and its potential in treating various medical conditions, further expanding the market's scope. R&D investments by pharmaceutical companies, academic institutions, and government agencies drive technological advancements and regulatory approvals, fostering market growth and shaping the future of CBD-based therapies.

Restraints/Challenges

• High Quality Control Challenges Limits the Adoption of Hemp-Derived Cannabidiol

Variations in cultivation methods, extraction processes, and product formulations can lead to inconsistencies in CBD product quality, potency, and purity. Without robust quality control measures, there's a risk of contamination with pesticides, heavy metals, and other impurities, compromising product safety. Additionally, the lack of standardized testing protocols and labeling requirements makes it difficult for consumers to assess product quality and efficacy.

• Growing Price Competition Hampers the Demand of Hemp-Derived Cannabidiol

With an abundance of suppliers and brands offering CBD products, intense competition drives prices lower, making it challenging for companies to maintain profitability and invest in research, development, and quality control. Price-driven competition can lead to compromises in product quality and safety as companies seek to reduce costs to remain competitive, potentially eroding consumer trust and market integrity. Moreover, price wars may discourage market entry for new players and deter investment in value-added services and innovation, stifling market evolution and differentiation.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In August 2021, L Catterton and Crown Laboratories announced the acquisition of StriVectin, reflecting a growing trend of major investments in skincare companies. This move could potentially influence the hemp-derived cannabidiol (CBD) market as skincare products often incorporate CBD for its purported benefits. With a focus on expanding skincare portfolios, this acquisition might lead to increased competition and innovation within the CBD skincare sector
• In June 2021, bioMérieux launched the REVEAL Rapid AST system in Europe, highlighting the importance of rapid diagnostic solutions in healthcare. While not directly related to hemp-derived CBD, advancements in diagnostic technology can indirectly impact the CBD market by promoting health awareness and facilitating better patient outcomes. Enhanced diagnostic capabilities could potentially drive demand for CBD products as consumers seek holistic wellness solutions
• In April 2021, Jordana Brewster collaborated with Clearblue for the Real Talk with Conceivinghood Campaign, shedding light on fertility issues. While fertility awareness may not directly intersect with the CBD market, campaigns promoting women's health and wellness align with the ethos of the CBD industry, which often emphasizes holistic approaches to well-being. Such collaborations contribute to a broader cultural conversation around health and wellness, potentially increasing interest in CBD products among health-conscious consumers

Hemp-Derived Cannabidiol Market Scope

The market is segmented on the basis of type, product type, application, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

Type

• Hemp Fiber
• Hemp Seed
• Hemp Seed Oil
• CBD Hemp Oil

Product Type

• Hemp-derived CBD Distillate
• Hemp-derived CBD Isolate
• Hemp-derived CBD Terpenes
• Others

Application

• Nutraceuticals
• Atopic Dermatitis
• Seizure
• Anxiety
• High Cholesterol
• Others

End-Users

• Clinic
• Hospital
• Others

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Hemp-Derived Cannabidiol Market Regional Analysis/Insights

The market is analyzed and market size information is provided by the country, type, product type, application, end-users and distribution channel as referenced above.

The countries covered in the market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

North America dominates in the market due to a robust demand for CBD distillate for its medicinal applications, driving consumption. Heightened awareness surrounding the benefits of hemp-derived CBD has spurred its popularity. Additionally, the region's high disposable income allows for greater spending on wellness products such as CBD. North America's well-established healthcare infrastructure facilitates distribution and access to CBD products, further fueling market dominance.

Asia-Pacific is expected for growth in the market, primarily fueled by escalating research and development endeavors. Increased investments in the healthcare sector, coupled with robust government support, further propel this trajectory. These factors converge to foster innovation, technological advancement, and enhanced healthcare infrastructure, positioning the region for significant economic and societal development in the forecast period.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the market. The data is available for historic period 2016-2021.

Competitive Landscape and Hemp-Derived Cannabidiol Market Analysis

시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 애플리케이션 우세입니다. 위에 제공된 데이터 포인트는 시장과 관련된 회사의 초점에만 관련이 있습니다.

시장에서 활동하는 주요 기업은 다음과 같습니다.

• Groff North America Hemplex(미국)
• Biophore(인도)
• 존슨 매티(영국)
• 큐리아 주식회사 (미국)
• 파장(미국)
• 노람코(미국)
• 퓨리시스(미국)
• Xi'an Tian Guangyuan Biotech Co., Ltd.(중국)
• 아그노파마(미국)

SKU-66534